Drug interactions related to self-medication: a French pharmacovigilance database study.


Journal

Fundamental & clinical pharmacology
ISSN: 1472-8206
Titre abrégé: Fundam Clin Pharmacol
Pays: England
ID NLM: 8710411

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 19 12 2019
revised: 03 02 2020
accepted: 13 02 2020
pubmed: 18 2 2020
medline: 9 6 2021
entrez: 18 2 2020
Statut: ppublish

Résumé

Self-medication (SM) is a common practice perceived by patients as harmless which can, however, entail health risks. The aim of the study was to identify drug-drug interactions (DDIs) involving SM drugs leading to adverse drug reactions (ADRs) in the National French Pharmacovigilance Database. All ADR reports from 1 January 1985 to 31 July 312018, coded as 'interaction' and 'self-medication', were selected and studied. Patient characteristics, the level and type of interaction, and the therapeutic classes of the drugs were examined. Adverse drug reactions were analysed and classified according to the system organ classes of the Medical Dictionary for Regulatory Activities. One hundred and three reports totalling 158 ADRs (71% severe cases) were included; 153 DDIs (59.5% pharmacodynamic) involving 234 drugs were identified. The latter included 119 SM drugs (51% available on prescription), mainly analgaesics, anti-inflammatory drugs, dietary supplements and antibiotics. Haemostasis disorders and renal failure were the most frequently reported ADRs. The analysis of reference documents raised concerns on the lack of information provided by package leaflets. In conclusion, the present study highlights the risks of medically unapproved re-use of prescription drugs or the consumption of dietary supplements without monitoring possible interactions and ADRs. Patient awareness could be improved by more regular updates of medication package inserts.

Identifiants

pubmed: 32064672
doi: 10.1111/fcp.12546
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

623-631

Informations de copyright

© 2020 Société Française de Pharmacologie et de Thérapeutique.

Références

Jerez-Roig J., Medeiros L.F.B., Silva V.A.B. et al. Prevalence of self-medication and associated factors in an elderly population: a systematic review. Drugs Aging (2014) 31 883-896.
Gualano M.R., Bert F., Passi S. et al. Use of self-medication among adolescents: a systematic review and meta-analysis. Eur. J. Public Health (2015) 25 444-450.
Montastruc J.-L., Bondon-Guitton E., Abadie D. et al. Pharmacovigilance, risks and adverse effects of self-medication. Therapie (2016) 71 257-262.
https://apps.who.int/medicinedocs/en/d/Jwhozip32e/WHO. Guidelines for the Regulatory Assessment of Medicinal Products for Use in Self-Medication, Geneva. 2000. Available: https://apps.who.int/medicinedocs/pdf/s2218e/s2218e.pdf. Accessed May 5, 2019
Ruiz M.E. Risks of self-medication practices. Curr. Drug Saf. (2010) 5 315-323.
Schmiedl S., Rottenkolber M., Hasford J. et al. Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study. Drug Saf. (2014) 37 225-235.
Asseray N., Ballereau F., Trombert-Paviot B. et al. Frequency and severity of adverse drug reactions due to self-medication: a cross-sectional multicentre survey in emergency departments. Drug Saf. (2013) 36 1159-1168.
Indermitte J., Reber D., Beutler M., Bruppacher R., Hersberger K.E. Prevalence and patient awareness of selected potential drug interactions with self-medication. J. Clin. Pharm. Ther. (2007) 32 149-159.
Stevenson R., MacWalter R.S., Harmse J.D., Wilson E. Mortality during the winter flu epidemic-two cases of death associated with self-medication. Scott. Med. J. (2001) 46 84-86.
https://ansm.sante.fr/var/ansm_site/storage/original/application/a90a7e83a649086c46aa73ea1f9e1b56.pdf. Accessed March 11, 2019.
Bismuth M., Oustric S., Boyer P. et al. Family pharmacy: survey of a sample of patients in Midi-Pyrénées. Therapie (2011) 66 131-134.
Ilhan M.N., Durukan E., Ilhan S.O., Aksakal F.N., Ozkan S., Bumin M.A. Self-medication with antibiotics: questionnaire survey among primary care center attendants. Pharmacoepidemiol Drug. Saf. (2009) 18 1150-1157.
Ivanovska V., Zdravkovska M., Bosevska G., Angelovska B. Antibiotics for upper respiratory infections: public knowledge, beliefs and self-medication in the Republic of Macedonia. Pril Makedon Akad Na Nauk Umet Oddelenie Za Med Nauki (2013) 34 59-70.
Palazzolo J. Le comportement d’automédication chez les plus de 65ans : une étude qualitative en médecine générale. NPG Neurol - Psychiatr - Gériatrie (2017) 17 63-69.
Baumelou A., Lauraire S., Tachot S., Flachaire M.Automédication. EMC (Elsevier SAS, Paris), Traité de Médecine Akos (2006) 1-0153
Ghane Shahrbaf F., Assadi F. Drug-induced renal disorders. J. Ren. Inj. Prev. (2015) 4 57-60.
Ungprasert P., Cheungpasitporn W., Crowson C.S., Matteson E.L. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies. Eur. J. Intern. Med. (2015) 26 285-291.
Moore N., Pollack C., Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther. Clin. Risk. Manag. (2015) 11 1061-1075.
Hersh E.V., Pinto A., Moore P.A. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin. Ther. (2007) 29(Suppl) 2477-2497.
Sørensen R., Olesen J.B., Charlot M., Gislason G.H. Risk of bleeding related to antithrombotic treatment in cardiovascular disease. Curr. Pharm. Des. (2012) 18 5362-5378.
Janoly-Duménil A., Bourne C., Loiseau K. et al. Oral anticoagulant treatment - evaluating the knowledge of patients admitted in physical medicine and rehabilitation units. Ann. Phys. Rehabil. Med. (2011) 54 172-180.
Cicero A.F.G., Ferroni A., Ertek S. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects. Expert Opin. Drug Saf. (2012) 11 753-766.
Poppenga R.H. Risks associated with the use of herbs and other dietary supplements. Vet. Clin. North Am. Equine Pract. (2001) 17 455-477.
https://www.anses.fr/fr/content/l%E2%80%99anses-recommande-%C3%A0-certaines-populations-d%E2%80%99%C3%A9viter-la-consommation-de-compl%C3%A9ments-0. Accessed April 19, 2019.
https://www.anses.fr/fr/content/les-compl%C3%A9ments-alimentaires-%C3%A0-vis%C3%A9e-articulaire-d%C3%A9conseill%C3%A9s-%C3%A0-certaines-populations. Accessed April 19, 2019
Chiba T., Sato Y., Nakanishi T., Yokotani K., Suzuki S., Umegaki K. Inappropriate usage of dietary supplements in patients by miscommunication with physicians in Japan. Nutrients (2014) 6 5392-5404.
Berreni A., Montastruc F., Bondon-Guitton E. et al. Adverse drug reactions to self-medication: a study in a pharmacovigilance database. Fundam. Clin. Pharmacol. (2015) 29(5) 517-520.
https://www.ansm.sante.fr/S-informer/Points-d-information-Points-d-information/L-ANSM-renforce-l-information-des-patients-et-des-pharmaciens-sur-les-risques-lies-aux-vasoconstricteurs-Point-d-information

Auteurs

Robin Vacher (R)

Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, F-49100, Angers, France.
Université d'Angers, 40 rue de Rennes, F-49035, Angers, France.

Laurence Lagarce (L)

Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, F-49100, Angers, France.

Sarah Ghamrawi (S)

Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, F-49100, Angers, France.

Delphine Laugier-Castellan (D)

Centre Régional de Pharmacovigilance, Marseille-Provence-Corse, Service de Pharmacologie Clinique et Pharmacovigilance, Aix Marseille Université, Assistance Publique des Hôpitaux de Marseille, 270, Boulevard de Sainte-Marguerite, F-13274, Marseille, France.

Thierry Vial (T)

Service Hospitalo-Universitaire de Pharmacologie-Toxicologie, Centre régional de Pharmacovigilance, Hospices Civils de Lyon, 3 Quai des Célestins, F-69002, Lyon, France.

Haleh Bagheri (H)

Service de Pharmacologie Clinique, Centre Régional de Pharmacovigilance, Centre Hospitalo-Universitaire, 9 Place Lange, F-31300, Toulouse, France.

Marina Babin (M)

Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, F-49100, Angers, France.

Marie Briet (M)

Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, F-49100, Angers, France.
Université d'Angers, 40 rue de Rennes, F-49035, Angers, France.
Laboratoire MitoVasc, UMR CNRS 6215, INSERM 1083, 3 rue Roger Amsler, F-49100, Angers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH